These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19734041)

  • 1. Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma.
    Verhoeff JJ; Stalpers LJ; Claes A; Hovinga KE; Musters GD; Peter Vandertop W; Richel DJ; Leenders WP; van Furth WR
    Eur J Cancer; 2009 Nov; 45(17):3074-80. PubMed ID: 19734041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.
    Verhoeff JJ; Stalpers LJ; Van Noorden CJ; Troost D; Ramkema MD; van Bree C; Song JY; Donker M; Chekenya M; Vandertop WP; Richel DJ; van Furth WR
    Cancer Lett; 2009 Nov; 285(1):39-45. PubMed ID: 19473756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.
    de Boüard S; Herlin P; Christensen JG; Lemoisson E; Gauduchon P; Raymond E; Guillamo JS
    Neuro Oncol; 2007 Oct; 9(4):412-23. PubMed ID: 17622648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
    Miletic H; Niclou SP; Johansson M; Bjerkvig R
    Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.
    Kunkel P; Ulbricht U; Bohlen P; Brockmann MA; Fillbrandt R; Stavrou D; Westphal M; Lamszus K
    Cancer Res; 2001 Sep; 61(18):6624-8. PubMed ID: 11559524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
    Hall WA; Vallera DA
    Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The radiosensitizing effect of CpG ODN107 on human glioma cells is tightly related to its antiangiogenic activity via suppression of HIF-1α/VEGF pathway.
    Liu D; Cao G; Cen Y; Liu T; Peng W; Sun J; Li X; Zhou H
    Int Immunopharmacol; 2013 Oct; 17(2):237-44. PubMed ID: 23791618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy.
    Dominietto M; Dobosz M; Bürgi S; Renner A; Zahlmann G; Scheuer W; Rudin M
    Eur Radiol; 2017 Jul; 27(7):2894-2902. PubMed ID: 27830379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.
    Ng EW; Shima DT; Calias P; Cunningham ET; Guyer DR; Adamis AP
    Nat Rev Drug Discov; 2006 Feb; 5(2):123-32. PubMed ID: 16518379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model.
    Hendriksen EM; Span PN; Schuuring J; Peters JP; Sweep FC; van der Kogel AJ; Bussink J
    Microvasc Res; 2009 Mar; 77(2):96-103. PubMed ID: 19118564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.
    Nedergaard MK; Michaelsen SR; Urup T; Broholm H; El Ali H; Poulsen HS; Stockhausen MT; Kjaer A; Lassen U
    PLoS One; 2015; 10(2):e0115315. PubMed ID: 25680186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma.
    Jiang F; Zhang X; Kalkanis SN; Zhang Z; Yang H; Katakowski M; Hong X; Zheng X; Zhu Z; Chopp M
    Photochem Photobiol; 2008; 84(1):128-37. PubMed ID: 18173712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
    Saidi A; Hagedorn M; Allain N; Verpelli C; Sala C; Bello L; Bikfalvi A; Javerzat S
    Int J Cancer; 2009 Sep; 125(5):1054-64. PubMed ID: 19431143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines--a clue to radioresistance?
    Hovinga KE; Stalpers LJ; van Bree C; Donker M; Verhoeff JJ; Rodermond HM; Bosch DA; van Furth WR
    J Neurooncol; 2005 Sep; 74(2):99-103. PubMed ID: 16193379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.
    Chinot OL
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1413-27. PubMed ID: 23249106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
    Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
    Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.